MicrobiologybioRxiv
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
F. Touret, J.-S. Driouich, M. Cochin…·A. Nougairede
This study evaluates Imatinib's antiviral potential against SARS-CoV-2 in vitro and in vivo, finding it ineffective in key models despite plasma and lung concentrations.